Drug Therapy

  1. madman

    Changing Landscape of ED: Shift in Risk Factors and Presentation Patterns

    https://academic.oup.com/jsm/article/21/Supplement_1/qdae001.228/7600739 Abstract Introduction Roughly 52% of men over the age of 40 have ED. However, our understanding of ED risk factors is constantly evolving. Objective The aim of this study is to provide a contemporary update of risk...
  2. madman

    Management of ED in men with diabetes mellitus unresponsive to PDE5i

    ABSTRACT Introduction. Erectile dysfunction (ED) is associated with diabetes mellitus with an estimated prevalence of 52.5% in the diabetic population. The first-line therapy for ED is phosphodiesterase type 5 inhibitors (PDE5i), but data suggest that diabetic men may be less responsive than...
  3. madman

    Contemporary and Emerging Pharmacotherapies for Peyronie’s Disease (Bent Penis)

    Pharmacotherapy in Peyronie’s disease: a state-of-the-art review on established contemporary and emerging drugs (2022) Eric Chung & Faysal A. Yafi ABSTRACT Introduction: Current clinical guidelines on Peyronie’s disease (PD) advocate non-surgical treatment options as the first-line therapy...
Back
Top